This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ibrahim UA, Ahmed SG. Pathophysiology of bleeding diathesis in haemophilia A: A sequential and critical appraisal of non-FVIII related haemostatic dysfunctions and their therapeutic implications. Egypt J Med Hum Genet 2018; 19: 285–95. doi: 10.1016/j.ejmhg.2018.01.003.IbrahimUAAhmedSGPathophysiology of bleeding diathesis in haemophilia A: A sequential and critical appraisal of non-FVIII related haemostatic dysfunctions and their therapeutic implicationsEgypt J Med Hum Genet2018192859510.1016/j.ejmhg.2018.01.003Open DOISearch in Google Scholar
Brinkmann T, Kähnert H, Prohaska W, et al. Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 1994; 32: 313–317.BrinkmannTKähnertHProhaskaWet alSynthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacsEur J Clin Chem Clin Biochem19943231331710.1515/cclm.1994.32.4.3137518699Search in Google Scholar
Nieuwenhuizen L, Schutgens RE, van Asbeck BS, et al. Identification and expression of iron regulators in human synovium: evidence for up-regulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controls. Haemophilia 2013;19: e218–e227. doi:10.1111/hae.12208.NieuwenhuizenLSchutgensREvan AsbeckBSet alIdentification and expression of iron regulators in human synovium: evidence for up-regulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controlsHaemophilia201319e218e22710.1111/hae.1220823777533Open DOISearch in Google Scholar
Qasim Z, Naseem L, Asif N, Hassan K. Haemophilia: pattern of clinical presentation and disease severity. Int J Pathol 2013; 11: 58–63.QasimZNaseemLAsifNHassanKHaemophilia: pattern of clinical presentation and disease severityInt J Pathol2013115863Search in Google Scholar
Ibrahim UA, Ahmed SG, Kagu MB, Abjah UA. Frequency and clinical significance of schistosomiasis in haemophilia. J Haem Pract 2016; 3: 39–43. doi: 10.17225/jhp00074.IbrahimUAAhmedSGKaguMBAbjahUAFrequency and clinical significance of schistosomiasis in haemophiliaJ Haem Pract20163394310.17225/jhp00074Open DOISearch in Google Scholar
Ibrahim UA, Ahmed SG, Kagu MB, Abjah UA. Impact of intestinal helminths on the risks of gastrointestinal haemorrhage and iron deficiency among haemophilia patients in northern Nigeria. J Haem Pract 2017; 4: 1–7. doi:10.17225/ jhp00097.IbrahimUAAhmedSGKaguMBAbjahUAImpact of intestinal helminths on the risks of gastrointestinal haemorrhage and iron deficiency among haemophilia patients in northern NigeriaJ Haem Pract201741710.17225/jhp00097Open DOISearch in Google Scholar
Ahmed SG, Kagu MB, Ibrahim UA, Bukar AA. Frequency of iron deficiency among patients with haemophilia-A in northern Nigeria: correlation with the disease severity and clinical Implications. Egypt J Haematol 2015; 40: 85–9. doi:10.4103/1110-1067.161294.AhmedSGKaguMBIbrahimUABukarAAFrequency of iron deficiency among patients with haemophilia-A in northern Nigeria: correlation with the disease severity and clinical ImplicationsEgypt J Haematol20154085910.4103/1110-1067.161294Open DOISearch in Google Scholar
Ghosh K, Ghosh K. Management of haemophilia in developing countries: challenges and options. Indian J Haematol Blood Transfus 2016; 32:347–55. doi:10.1007/s12288-015-0562-x.GhoshKGhoshKManagement of haemophilia in developing countries: challenges and optionsIndian J Haematol Blood Transfus2016323475510.1007/s12288-015-0562-x493074927429529Open DOISearch in Google Scholar
Ahmed SG, Kagu MB, Ibrahim UA. Pattern of blood products transfusions and reactions among multi-transfused haemophiliacs in Nigeria: implications on haemophilia care in low resource tropical settings. Sudan Med J 2018, 54: 29–38. doi: 10.12816/0046389.AhmedSGKaguMBIbrahimUAPattern of blood products transfusions and reactions among multi-transfused haemophiliacs in Nigeria: implications on haemophilia care in low resource tropical settingsSudan Med J201854293810.12816/0046389Open DOISearch in Google Scholar
Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011; 2:7. doi: 10.2147/JBM.S17194.OsaroECharlesATThe challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic bloodJ Blood Med20112710.2147/JBM.S17194326234922287859Open DOISearch in Google Scholar
Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012; 26: 164–80. doi:10.1016/j.tmrv.2011.07.006.BlochEMVermeulenMMurphyEBlood transfusion safety in Africa: a literature review of infectious disease and organizational challengesTransfus Med Rev2012261648010.1016/j.tmrv.2011.07.006366866121872426Open DOISearch in Google Scholar
Nwankwo E, Momodu I, Umar I, et al. Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria. Turk J Med 2012; 42: 337–41. doi:10.3906/sag-1009-1176.NwankwoEMomoduIUmarIet alSeroprevalence of major blood-borne infections among blood donors in Kano, NigeriaTurk J Med2012423374110.3906/sag-1009-1176Open DOISearch in Google Scholar
Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health 2018; 18: 645. doi: 10.1186/ s12889-018-5555-x.OkoroiwuHUOkaforIMAsemotaEAOkpokamDCSeroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluationBMC Public Health20181864510.1186/s12889-018-5555-x596495229788937Open DOISearch in Google Scholar
Abimiku AG, Zwandor A, Gomwalk N, et al. HIV-1, not HIV-2, is prevalent in Nigeria: need for consideration in vaccine plans. Vaccine Res 1994; 3: 101–4.AbimikuAGZwandorAGomwalkNet alHIV-1, not HIV-2, is prevalent in Nigeria: need for consideration in vaccine plansVaccine Res199431014Search in Google Scholar
Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian J Transfus Sci 2017; 11: 1–5. doi: 10.4103/0973-6247.200781.AnekeJCOkochaCEBlood transfusion safety; current status and challenges in NigeriaAsian J Transfus Sci2017111510.4103/0973-6247.200781534527328316432Open DOISearch in Google Scholar
Osaro E, Mohammed N, Zama I, et al. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria-the question of safety of blood transfusion in Nigeria. Pan Afr Med J 2014; 18. doi: 10.11604/pamj.2014.18.174.3449.OsaroEMohammedNZamaIet alPrevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria-the question of safety of blood transfusion in NigeriaPan Afr Med J20141810.11604/pamj.2014.18.174.3449423692525419301Open DOISearch in Google Scholar
Lieshout-Krikke RW, Zaaijer HL, van de Laar TJW. Predonation screening of candidate donors and prevention of window period donations. Transfusion 2015; 55: 373–8.Lieshout-KrikkeRWZaaijerHLvan de LaarTJWPredonation screening of candidate donors and prevention of window period donationsTransfusion201555373810.1111/trf.1280925130605Search in Google Scholar
Stonebraker JS, Bolton-Maggs PH, Soucie JM, et al. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010;16:20–32. doi: 10.1111/j.1365-2516.2009.02127.x.StonebrakerJSBolton-MaggsPHSoucieJMet alA study of variations in the reported haemophilia A prevalence around the worldHaemophilia201016203210.1111/j.1365-2516.2009.02127.x19845775Open DOISearch in Google Scholar
Laffan M, Manning R. Investigation of haemostasis. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology 10th edn. London, Churchill Livingstone; 2006: 379–440.LaffanMManningRInvestigation of haemostasisInLewisSMBainBJBatesIedsPractical Haematology10th ednLondonChurchill Livingstone200637944010.1016/B0-44-306660-4/50020-9Search in Google Scholar
Olayinka AT, Oyemakinde A, Balogun MS, et al. Seroprevalence of hepatitis B infection in Nigeria: a national survey. Am J Trop Med Hyg 2016; 95: 902–7. doi: 10.4269/ajtmh.15-0874.OlayinkaATOyemakindeABalogunMSet alSeroprevalence of hepatitis B infection in Nigeria: a national surveyAm J Trop Med Hyg201695902710.4269/ajtmh.15-0874506279827527630Open DOISearch in Google Scholar
Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J 2013; 14: 44. doi: 10.11604/ pamj.2013.14.44.2199.KaroneyMJSiikaAMHepatitis C virus (HCV) infection in Africa: a reviewPan Afr Med J2013144410.11604/pamj.2013.14.44.2199361290123560127Open DOISearch in Google Scholar
Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci 2018; 25: 697–703. doi: 10.1016/j.sjbs.2016.03.006.AwofalaAAOgundeleOEHIV epidemiology in NigeriaSaudi J Biol Sci20182569770310.1016/j.sjbs.2016.03.006593701329740232Open DOISearch in Google Scholar
Keechilot CS, Shenoy V, Kumar A, et al. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Global Health 2016; 110: 287291. doi: 10.1080/20477724.2016.1248171.KeechilotCSShenoyVKumarAet alDetection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South IndiaPathog Global Health201611028729110.1080/20477724.2016.1248171Open DOISearch in Google Scholar
Mehra B, Bhattar S, Bhalla P, Rawat D. Rapid tests versus ELISA for screening of HIV infection: our experience from a voluntary counselling and testing facility of a tertiary care centre in North India. ISRN AIDS 2014; 2014: 296840. doi: 10.1155/2014/296840.MehraBBhattarSBhallaPRawatDRapid tests versus ELISA for screening of HIV infection: our experience from a voluntary counselling and testing facility of a tertiary care centre in North IndiaISRN AIDS2014201429684010.1155/2014/296840Open DOISearch in Google Scholar
Orkuma JA, Egesie JO, Banwat EB, et al. HIV screening in blood donors: rapid diagnostic test versus enhanced ELISA. Niger J Med 2014; 23: 192–200.OrkumaJAEgesieJOBanwatEBet alHIV screening in blood donors: rapid diagnostic test versus enhanced ELISANiger J Med201423192200Search in Google Scholar
Yang JF, Lin YY, Hsieh MH, et al. Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups. Kaohsiung J Med Sci 2011; 27: 258–63. doi: 10.1016/j.kjms.2010.11.007.YangJFLinYYHsiehMHet alPerformance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groupsKaohsiung J Med Sci2011272586310.1016/j.kjms.2010.11.007Open DOISearch in Google Scholar
Chigurupati P, Murthy KS. Automated nucleic acid amplification testing in blood banks: an additional layer of blood safety. Asian J Transfus Sci 2015; 9: 9–11. doi: 10.4103/0973-6247.150938.ChigurupatiPMurthyKSAutomated nucleic acid amplification testing in blood banks: an additional layer of blood safetyAsian J Transfus Sci2015991110.4103/0973-6247.150938Open DOISearch in Google Scholar
Devine DV, Schubert P. Pathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety risk. Hematol Oncol Clin 2016; 30: 609–17. doi: 10.1016/j.hoc.2016.01.005.DevineDVSchubertPPathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety riskHematol Oncol Clin2016306091710.1016/j.hoc.2016.01.005Open DOISearch in Google Scholar
Chaabna K, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PLoS ONE 2016; 11(2): e0149966-e0149966. doi: 10.1371/journal.pone.0149966.ChaabnaKKouyoumjianSPAbu-RaddadLJHepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysisPLoS ONE2016112e0149966e014996610.1371/journal.pone.0149966Open DOISearch in Google Scholar
Abdelwahab MS, El-Raziky MS, Kaddah NA, Abou-Elew HH. Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children. Ann Saudi Med 2012; 32: 200–2. doi: 10.5144/02564947.2012.200.AbdelwahabMSEl-RazikyMSKaddahNAAbou-ElewHHPrevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac childrenAnn Saudi Med201232200210.5144/02564947.2012.200Open DOISearch in Google Scholar
Borhany M, Shamsi T, Boota S, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost 2011; 17: 651–5. doi: 10.1177/1076029611398122.BorhanyMShamsiTBootaSet alTransfusion transmitted infections in patients with hemophilia of Karachi, PakistanClin Appl Thromb Hemost201117651510.1177/1076029611398122Open DOISearch in Google Scholar
Makris M, Preston FE. Chronic hepatitis in haemophilia. Blood Rev 1993; 7: 243–50. doi: 10.1016/0268-960X(93)90011-R.MakrisMPrestonFEChronic hepatitis in haemophiliaBlood Rev199372435010.1016/0268-960X(93)90011-ROpen DOISearch in Google Scholar
Heinz S, Braspenning J. Measurement of blood coagulation factor synthesis in cultures of human hepatocytes. Methods Mol Biol 2015; 1250: 309–16. doi: 10.1007/978-1-4939-20747_23.HeinzSBraspenningJMeasurement of blood coagulation factor synthesis in cultures of human hepatocytesMethods Mol Biol201512503091610.1007/978-1-4939-20747_23Open DOISearch in Google Scholar
Lim SG, Lee CA, Kernoff PB. The treatment of HIV associated thrombocytopenia in haemophiliacs. Int J Lab Hematol 1990; 12: 237–45. doi: 10.1111/j.1365-2257.1990.tb00033.x.LimSGLeeCAKernoffPBThe treatment of HIV associated thrombocytopenia in haemophiliacsInt J Lab Hematol1990122374510.1111/j.1365-2257.1990.tb00033.x1703063Open DOISearch in Google Scholar
Lee CA. Blood borne infections and haemophilia: the worst of times. J Haem Pract 2015; 2: 5–7. doi: 10.17225/jhp00049.LeeCABlood borne infections and haemophilia: the worst of timesJ Haem Pract201525710.17225/jhp00049Open DOISearch in Google Scholar
Loomans JI, Kruip MJ, Carcao M, et al. Desmopressin in moderate hemophilia-A patients: a treatment worth considering. Haematologica 2018; 103: 550–7. doi: 10.3324/ haematol.2017.180059.LoomansJIKruipMJCarcaoMet alDesmopressin in moderate hemophilia-A patients: a treatment worth consideringHaematologica2018103550710.3324/haematol.2017.180059583039329305412Open DOISearch in Google Scholar
Hart D, Badle S. Anti-fibrinolytic agents in bleeding disorders – a clinical perspective. J Haem Pract 2016; 3: 1–4. doi: 10.17225/jhp00089.HartDBadleSAnti-fibrinolytic agents in bleeding disorders – a clinical perspectiveJ Haem Pract201631410.17225/jhp00089Open DOISearch in Google Scholar
